0000000000431948

AUTHOR

Durelli L.

showing 1 related works from this author

Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP).

2013

Multiple Sclerosis Natalizumab TySTOPSettore MED/26 - Neurologia
researchProduct